Acuamark Diagnostics
Joseph Smith is previously an Executive VP BD and General Counsel of Cepheid (now Danaher), Sr. VP BD at Applied Biosystems (ABI), VP Intellectual Property at ABI and PE Biosystems (Perkin-Elmer). Responsible for building and designing ABI's IP acquisition strategy, expanding its IP estate in fields such as PCR thermal cyclers, PCR reagents and DNA sequencing.
This person is not in the org chart
This person is not in any offices
Acuamark Diagnostics
Acuamark Diagnostics (formerly iCareDx) develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable.